Induction of Apoptosis by Ethanol Extracts of Ganoderma lucidum in Human Gastric Carcinoma Cells

JAMS Journal of Acupuncture and Meridian Studies

Volumn 3, Issue 1, 2010, Pages 24-31

  Jang, Kyung Jun ^a   Han, Min Ho ^a   Lee, Byung Hoon ^a   Kim, Byung Woo ^a   Kim, Cheol Hong ^a   Yoon, Hyun Min ^a   Choi, Yung Hyun ^a  

^a Dong Eui University   (South Korea)

Author keywords

AGS; Akt; apoptosis; caspase; Ganoderma lucidum

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ALCOHOL; CASPASE 3; CASPASE 8; CASPASE 9; DEATH RECEPTOR 5; GANODERMA LUCIDUM EXTRACT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN KINASE B; PROTEIN KINASE B BETA; SURVIVIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; X LINKED INHIBITOR OF APOPTOSIS; CASPASE; PLANT EXTRACT;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL DEATH; CELL VIABILITY; CHROMATIN CONDENSATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; GANODERMA LUCIDUM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STOMACH CARCINOMA; CARCINOMA; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; STOMACH NEOPLASMS; TUMOR CELL LINE;

APOPTOSIS; CARCINOMA; CASPASES; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PLANT EXTRACTS; REISHI; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 77950295383     PISSN: 20052901     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2005-2901(10)60004-0     Document Type: Article

References (30)

1. Ghobrial I.M., Witzig T.E., and Adjei A.A. Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 55 (2005) 178-194
2. Han S.I., Kim Y.S., and Kim T.H. Role of apoptotic and necrotic cell death under physiologic conditions. BMB Rep 41 (2008) 1-10
3. Jin Z., and El-Deiry W.S. Overview of cell death signaling pathways. Cancer Biol Ther 4 (2005) 39-163
4. Jeong S.Y., and Seol D.W. The role of mitochondria in apoptosis. BMB Rep 41 (2008) 11-22
5. Wesche-Soldato D.E., Swan R.Z., Chung C.S., and Ayala A. The apoptotic pathway as a therapeutic target in sepsis. Curr Drug Targets 8 (2007) 493-500
6. Galluzzi L., Larochette N., Zamzami N., and Kroemer G. Mitochondria as therapeutic targets for cancer chemotherapy. Oncogene 25 (2006) 4812-4830
7. Javadov S., and Karmazyn M. Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection. Cell Physiol Biochem 20 (2007) 1-22
8. Kennedy S.G., Wagner A.J., Conzen S.D., Jordan J., Bellacosa A., Tsichlis P.N., et al. The PI3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev 11 (1997) 701-713
9. Kim D., Cheng G.Z., Lindsley C.W., Yang H., and Cheng J.Q. Targeting the phosphatidylinositol-3 kinase/Akt pathway for the treatment of cancer. Curr Opin Investig Drugs 6 (2005) 1250-1258
10. Mahajna J., Dotan N., Zaidman B.Z., Petrova R.D., and Wasser S.P. Pharmacological values of medicinal mushrooms for prostate cancer therapy: the case of Ganoderma lucidum. Nutr Cancer 61 (2009) 16-26
11. Boh B., Berovic M., Zhang J., and Zhi-Bin L. Ganoderma lucidum and its pharmaceutically active compounds. Biotechnol Annu Rev 13 (2007) 265-301
12. Paterson R.R. Ganoderma: a therapeutic fungal biofactory. Phytochemistry 67 (2006) 1985-2001
13. Yuen J.W., and Gohel M.D. Anticancer effects of Ganoderma lucidum: a review of scientific evidence. Nutr Cancer 53 (2005) 11-17
14. Chen J.G., Yang C.P., Cammer M., and Horwitz S.B. Gene expression and mitotic exit induced by microtubule-stabilizing drugs. Cancer Res 63 (2003) 7891-7899
15. Chien C.M., Cheng J.L., Chang W.T., Tien M.H., Tsao C.M., Chang Y.H., et al. Polysaccharides of Ganoderma lucidum alter cell immunophenotypic expression and enhance CD56 + NK-cell cytotoxicity in cord blood. Bioorg Med Chem 12 (2004) 5603-5609
16. Lin Z.B. Cellular and molecular mechanisms of immunomodulation by Ganoderma lucidum. J Pharmacol Sci 99 (2005) 144-153
17. Hu H., Ahn N.S., Yang X., Lee Y.S., and Kang K.S. Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Int J Cancer 102 (2002) 250-253
18. Sliva D., Labarrere C., Slivova V., Sedlak M., Lloyd Jr. F.P., and Ho N.W. Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochem Biophys Res Commun 298 (2002) 603-612
19. Lin S.B., Li C.H., Lee S.S., and Kan L.S. Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogenactivated protein kinases and G2-phase cell cycle arrest. Life Sci 72 (2003) 2381-2390
20. Jiang J.H., Slivova V., Valachovicova T., Harvey K., and Sliva D. Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3. Int J Oncol 24 (2004) 1093-1099
21. Hong K.J., Dunn D.M., Shen C.L., and Pence B.C. Effects of Ganoderma lucidum on apoptotic and anti-inflammatory function in HT-29 human colonic carcinoma cells. Phytother Res 18 (2004) 768-770
22. Stanley G., Harvey K., Slivova V., Jiang J., and Sliva D. Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-a1 from prostate cancer cells. Biochem Biophys Res Commun 330 (2005) 46-52
23. Müller C.I., Kumagai T., O'Kelly J., Seeram N.P., Heber D., and Koeffler H.P. Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells. Leuk Res 30 (2006) 841-848
24. Liu Y.W., Gao J.L., Guan J., Qian Z.M., Feng K., and Li S.P. Evaluation of antiproliferative activities and action mechanisms of extracts from two species of Ganoderma on tumor cell lines. J Agric Food Chem 57 (2009) 3087-3093
25. Sadava D., Still D.W., Mudry R.R., and Kane S.E. Effect of Ganoderma on drug-sensitive and multidrug-resistant small-cell lung carcinoma cells. Cancer Lett 277 (2009) 182-189
26. Murphy A.N., Bredesen D.E., Cortopassi G., Wang E., and Fiskum G. Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc Natl Acad Sci USA 93 (1996) 9893-9898
27. Thees S., Hubbard G.B., Winckler J., Schultz C., and Rami A. Specific alteration of the Bax/Bcl2 ratio and cytochrome c without execution of apoptosis in the hippocampus of aged baboons. Restor Neurol Neurosci 23 (2005) 1-9
28. Eckelman B.P., Salvesen G.S., and Scott F.L. Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep 7 (2006) 988-994
29. Hunter A.M., LaCasse E.C., and Korneluk R.G. The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 12 (2007) 1543-1568
30. Lazebnik Y.A., Kaufmann S.H., Desnoyers S., Poirier G.G., and Earnshaw W.C. Cleavage of polyADP-ribose polymerase by a proteinase with properties like ICE. Nature 371 (1994) 346-347